6-Thioguanine resistance in a human colon carcinoma cell line with unaltered levels of hypoxanthine guanine phosphoribosyltransferase activity

International Journal of Cancer

Volumn 82, Issue 4, 1999, Pages 556-561

  Bemi, Valentina ^a   Turchi, Gino ^b   Margotti, Elisa ^a   Giorgelli, Francesco ^a   Pesi, Rossana ^a   Sgarrella, Francesco ^c   Tozzi, Maria Grazia ^c   Camici, Marcella ^a,d  

^a Dipto di Fisiologia e Biochimica   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

^d Dipto di Fisiologia e Biochimica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; TIOGUANINE;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; COLON CARCINOMA; DNA REPAIR; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG METABOLISM; DRUG UPTAKE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIMETABOLITES, ANTINEOPLASTIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; HT29 CELLS; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; NEOPLASM PROTEINS; THIOGUANINE; TUMOR CELLS, CULTURED;

EID: 0032837835     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990812)82:4<556::AID-IJC14>3.0.CO;2-Y     Document Type: Article

References (21)

1. 6-methylguanine and 6-thioguanine cytotoxic effects: a cross-resistant phenotype in N-methylnitrosurea-resistant Chinese hamster ovary cells. Cancer Res., 50, 4248-4253 (1990).
2. BESSEY, O.A., LOWRY, O.H. and BROCK, M.J., A method for the rapid determination of alkaline phosphatase with five cubic milliliters of serum. J. biol. Chem., 164, 321-329 (1946).
3. BRADFORD, M.M., A rapid and sensitive method for the quantisation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254 (1979).
4. CAMICI, M., TURRIANI, M., TOZZI, M.G., TURCHI, G., COS, J., ALEMANY, C., MIRALLES, A., NOE, V. and CIUDAD, C.J., Purine enzyme profile in human colon-carcinoma cell lines and differential sensitivity to deoxycoformycin and 2′-deoxyadenosine in combination. Int. J. Cancer, 62, 176-183 (1995).
5. GOEL, R. and HOWELL, S.B., Modulation of the activity of cancer chemotherapeutic agents by dipyridamole. In: F.M. Muggia (ed.), New drugs, concepts and results in cancer chemotherapy, pp. 19-44, Kluwer, Boston (1991).
6. HARRIS, J.F. and WHITMORE, G.F., Chinese hamster cells exhibiting a temperature dependent alteration in purine transport. J. Cell Physiol., 83, 43-51(1974).
7. KALCKAR, H.M., Differential spectrophotometry of purine compounds by means of specific enzymes. 1. Determination of hydroxypurine compounds. J. biol. Chem., 167, 429-443 (1947).
8. KANG, G.-J. and KIMBALL, A.P., Dipyridamole enhancement of toxicity to L1210 cells by deoxyadenosine and deoxycoformycin combinations in vitro. Cancer Res., 44, 461-466 (1984).
9. KIRDASZUK, B., BOHMAN, C., ULLMAN, B. and ERIKSSON, S., Substrate specificity of human deoxycytidine kinase toward antiviral 2′,3′-dideoxynucleoside analogs. Biochem. Pharmacol., 43, 197-206 (1992).
10. LENNARD, L., The clinical pharmacology of 6-mercaptopurine. Europ. J. Pharmacol., 43, 329-339 (1992).
11. LENNARD, L. and LILLEYMAN, J.S., Individualizing therapy with 6-mercaptopurine and 6-thioguanine related to the thiopurine methyltransferase genetic polymorphism. Ther. Drug Monit., 18, 328-334 (1996).
12. LING, Y-H., CHAN, J. Y., BEATTIE, K.L. and NELSON, J.A., Consequences of 6-thioguanine incorporation into DNA on polymerase ligase, and endonuclease reactions. Mol. Pharmacol., 42, 802-807 (1992).
13. MORGAN, C.J., CHAWDRY, R.N., SMITH, A.R., SIRAVO-SAGRAVES, G. and TREWYN, R.W., 6-Thioguanine-induced growth arrest in 6-mercaptopurine-resistant human leukemia cells. Cancer Res., 54, 5387-5393 (1994).
14. PLAGEMANN, P.G.W., MARZ, R., WOHLHUETER, R.M., GRAFF, J.C. and ZYLKA, J.M., Facilitated transport of 6-mercaptopurine and 6-thioguanine and non-mediated permeation of 8-azaguanine in Novikoff rat hepatoma cells and relationship to intracellular phosphoribosylation. Biochim. biophys. Acta, 21, 49-62 (1981).
15. rst) with normal level of hypoxanthine-guanine phosphoribosyltransferase activity. J. Cell. Biochem., 27, 109-120 (1985).
16. REMY, C.N., Metabolism of thiopyrimidines and thiopurines: S-methylation with S-adenosylmethionine transmethylase and catabolism in mammalian tissues. J. biol. Chem., 238, 819-826 (1963).
17. SWANN, P.F., WATERS, T.R., MOULTON, D.C., Xu, Y.-H., ZHENG, Q., EDWARDS, M. and MACE, R., Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science, 273, 1109-1111 (1996).
18. TURCHI, G., NARDONE, A. and PALITTI, F., Application of an epithelial liver cell line, metabolically competent, for mutation studies of promutagens. Mutation Res., 271, 79-88 (1992).
19. URIBE-LUNA, S., QUINTANA-HAU, J.D., MALDONADO-RODRIGUEZ, R., ESPINOSA-LARA, M., BEATTIE, K.L., FARQUHAR, D. and NELSON, J.A., Mutagenic consequences of the incorporation of 6-thioguanine into DNA. Biochem. Pharmacol., 54, 419-424 (1997).
20. 6-methylthioguanine. Biochemistry, 36, 2501-2506 (1997).
21. WEINSHILBOUM, R.M., RAYMOND, F.A. and PAZMIÑO, P.A., Human erythrocyte thiopurine methyltransferase: radiochemical microassays and biochemical properties. Clin. chim. Acta, 85, 323-333 (1978).